Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Ganga Pharmaceuticals Ltd (NSE: GANGAPHARM), ISIN INE615T01017 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
GANGAPHARM last traded at ₹12.50, with a 52-week range of ₹9.35 to ₹13.97 (as of 8 Sep 2026).
Shareholding as of Sep 2025: promoters 50.91%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 52/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.